nodes	percent_of_prediction	percent_of_DWPC	metapath
Pergolide—DRD5—G alpha (s) signalling events—SCT—duodenum cancer	0.0274	0.0274	CbGpPWpGaD
Pergolide—DRD1—G alpha (s) signalling events—SCT—duodenum cancer	0.0182	0.0182	CbGpPWpGaD
Pergolide—KCNH2—SIDS Susceptibility Pathways—SST—duodenum cancer	0.015	0.015	CbGpPWpGaD
Pergolide—HTR2B—G alpha (q) signalling events—GAST—duodenum cancer	0.0146	0.0146	CbGpPWpGaD
Pergolide—ADRA1D—G alpha (q) signalling events—GAST—duodenum cancer	0.0136	0.0136	CbGpPWpGaD
Pergolide—HTR2B—Gastrin-CREB signalling pathway via PKC and MAPK—GAST—duodenum cancer	0.0131	0.0131	CbGpPWpGaD
Pergolide—ADRA1D—Gastrin-CREB signalling pathway via PKC and MAPK—GAST—duodenum cancer	0.0122	0.0122	CbGpPWpGaD
Pergolide—HTR2C—G alpha (q) signalling events—GAST—duodenum cancer	0.0118	0.0118	CbGpPWpGaD
Pergolide—ADRA1B—G alpha (q) signalling events—GAST—duodenum cancer	0.0113	0.0113	CbGpPWpGaD
Pergolide—HTR2C—Gastrin-CREB signalling pathway via PKC and MAPK—GAST—duodenum cancer	0.0106	0.0106	CbGpPWpGaD
Pergolide—HTR2A—G alpha (q) signalling events—GAST—duodenum cancer	0.0103	0.0103	CbGpPWpGaD
Pergolide—ADRA1B—Gastrin-CREB signalling pathway via PKC and MAPK—GAST—duodenum cancer	0.0101	0.0101	CbGpPWpGaD
Pergolide—ADRA1A—G alpha (q) signalling events—GAST—duodenum cancer	0.01	0.01	CbGpPWpGaD
Pergolide—DRD5—GPCR ligand binding—SCT—duodenum cancer	0.00994	0.00994	CbGpPWpGaD
Pergolide—DRD5—Class A/1 (Rhodopsin-like receptors)—SST—duodenum cancer	0.00944	0.00944	CbGpPWpGaD
Pergolide—HTR1A—SIDS Susceptibility Pathways—SST—duodenum cancer	0.00941	0.00941	CbGpPWpGaD
Pergolide—HTR2A—Gastrin-CREB signalling pathway via PKC and MAPK—GAST—duodenum cancer	0.00918	0.00918	CbGpPWpGaD
Pergolide—HTR1D—G alpha (i) signalling events—SST—duodenum cancer	0.00909	0.00909	CbGpPWpGaD
Pergolide—ADRA1A—Gastrin-CREB signalling pathway via PKC and MAPK—GAST—duodenum cancer	0.00899	0.00899	CbGpPWpGaD
Pergolide—HTR1B—G alpha (i) signalling events—SST—duodenum cancer	0.0089	0.0089	CbGpPWpGaD
Pergolide—DRD4—G alpha (i) signalling events—SST—duodenum cancer	0.00876	0.00876	CbGpPWpGaD
Pergolide—HTR2A—SIDS Susceptibility Pathways—SST—duodenum cancer	0.00813	0.00813	CbGpPWpGaD
Pergolide—DRD3—G alpha (i) signalling events—SST—duodenum cancer	0.00778	0.00778	CbGpPWpGaD
Pergolide—HTR1D—GPCR ligand binding—SCT—duodenum cancer	0.00761	0.00761	CbGpPWpGaD
Pergolide—HTR1B—GPCR ligand binding—SCT—duodenum cancer	0.00745	0.00745	CbGpPWpGaD
Pergolide—DRD4—GPCR ligand binding—SCT—duodenum cancer	0.00733	0.00733	CbGpPWpGaD
Pergolide—HTR1D—Class A/1 (Rhodopsin-like receptors)—SST—duodenum cancer	0.00723	0.00723	CbGpPWpGaD
Pergolide—DRD5—GPCR ligand binding—SST—duodenum cancer	0.00718	0.00718	CbGpPWpGaD
Pergolide—HTR1B—Class A/1 (Rhodopsin-like receptors)—SST—duodenum cancer	0.00708	0.00708	CbGpPWpGaD
Pergolide—ADRA2B—G alpha (i) signalling events—SST—duodenum cancer	0.00702	0.00702	CbGpPWpGaD
Pergolide—HTR2B—GPCR ligand binding—SCT—duodenum cancer	0.007	0.007	CbGpPWpGaD
Pergolide—DRD4—Class A/1 (Rhodopsin-like receptors)—SST—duodenum cancer	0.00696	0.00696	CbGpPWpGaD
Pergolide—HTR1A—G alpha (i) signalling events—SST—duodenum cancer	0.00678	0.00678	CbGpPWpGaD
Pergolide—HTR2B—Class A/1 (Rhodopsin-like receptors)—SST—duodenum cancer	0.00665	0.00665	CbGpPWpGaD
Pergolide—DRD1—GPCR ligand binding—SCT—duodenum cancer	0.0066	0.0066	CbGpPWpGaD
Pergolide—ADRA2C—G alpha (i) signalling events—SST—duodenum cancer	0.00656	0.00656	CbGpPWpGaD
Pergolide—DRD3—GPCR ligand binding—SCT—duodenum cancer	0.00652	0.00652	CbGpPWpGaD
Pergolide—ADRA1D—GPCR ligand binding—SCT—duodenum cancer	0.00652	0.00652	CbGpPWpGaD
Pergolide—DRD1—Class A/1 (Rhodopsin-like receptors)—SST—duodenum cancer	0.00627	0.00627	CbGpPWpGaD
Pergolide—DRD3—Class A/1 (Rhodopsin-like receptors)—SST—duodenum cancer	0.00619	0.00619	CbGpPWpGaD
Pergolide—ADRA1D—Class A/1 (Rhodopsin-like receptors)—SST—duodenum cancer	0.00619	0.00619	CbGpPWpGaD
Pergolide—DRD2—G alpha (i) signalling events—SST—duodenum cancer	0.00595	0.00595	CbGpPWpGaD
Pergolide—DRD5—GPCR downstream signaling—GAST—duodenum cancer	0.00592	0.00592	CbGpPWpGaD
Pergolide—ADRA2B—GPCR ligand binding—SCT—duodenum cancer	0.00588	0.00588	CbGpPWpGaD
Pergolide—HTR1A—GPCR ligand binding—SCT—duodenum cancer	0.00568	0.00568	CbGpPWpGaD
Pergolide—HTR2C—GPCR ligand binding—SCT—duodenum cancer	0.00565	0.00565	CbGpPWpGaD
Pergolide—DRD5—GPCR downstream signaling—SCT—duodenum cancer	0.00562	0.00562	CbGpPWpGaD
Pergolide—ADRA2B—Class A/1 (Rhodopsin-like receptors)—SST—duodenum cancer	0.00558	0.00558	CbGpPWpGaD
Pergolide—HTR1D—GPCR ligand binding—SST—duodenum cancer	0.0055	0.0055	CbGpPWpGaD
Pergolide—ADRA2C—GPCR ligand binding—SCT—duodenum cancer	0.00549	0.00549	CbGpPWpGaD
Pergolide—ADRA1B—GPCR ligand binding—SCT—duodenum cancer	0.00541	0.00541	CbGpPWpGaD
Pergolide—HTR1A—Class A/1 (Rhodopsin-like receptors)—SST—duodenum cancer	0.00539	0.00539	CbGpPWpGaD
Pergolide—HTR1B—GPCR ligand binding—SST—duodenum cancer	0.00539	0.00539	CbGpPWpGaD
Pergolide—DRD5—Signaling by GPCR—GAST—duodenum cancer	0.00538	0.00538	CbGpPWpGaD
Pergolide—HTR2C—Class A/1 (Rhodopsin-like receptors)—SST—duodenum cancer	0.00536	0.00536	CbGpPWpGaD
Pergolide—ADRA2A—G alpha (i) signalling events—SST—duodenum cancer	0.00533	0.00533	CbGpPWpGaD
Pergolide—DRD4—GPCR ligand binding—SST—duodenum cancer	0.0053	0.0053	CbGpPWpGaD
Pergolide—ADRA2C—Class A/1 (Rhodopsin-like receptors)—SST—duodenum cancer	0.00522	0.00522	CbGpPWpGaD
Pergolide—ADRA1B—Class A/1 (Rhodopsin-like receptors)—SST—duodenum cancer	0.00513	0.00513	CbGpPWpGaD
Pergolide—DRD5—Signaling by GPCR—SCT—duodenum cancer	0.0051	0.0051	CbGpPWpGaD
Pergolide—HTR2B—GPCR ligand binding—SST—duodenum cancer	0.00506	0.00506	CbGpPWpGaD
Pergolide—DRD2—GPCR ligand binding—SCT—duodenum cancer	0.00499	0.00499	CbGpPWpGaD
Pergolide—HTR2A—GPCR ligand binding—SCT—duodenum cancer	0.00491	0.00491	CbGpPWpGaD
Pergolide—ADRA1A—GPCR ligand binding—SCT—duodenum cancer	0.0048	0.0048	CbGpPWpGaD
Pergolide—DRD1—GPCR ligand binding—SST—duodenum cancer	0.00477	0.00477	CbGpPWpGaD
Pergolide—DRD2—Class A/1 (Rhodopsin-like receptors)—SST—duodenum cancer	0.00473	0.00473	CbGpPWpGaD
Pergolide—DRD3—GPCR ligand binding—SST—duodenum cancer	0.00471	0.00471	CbGpPWpGaD
Pergolide—ADRA1D—GPCR ligand binding—SST—duodenum cancer	0.00471	0.00471	CbGpPWpGaD
Pergolide—HTR2A—Class A/1 (Rhodopsin-like receptors)—SST—duodenum cancer	0.00466	0.00466	CbGpPWpGaD
Pergolide—ADRA1A—Class A/1 (Rhodopsin-like receptors)—SST—duodenum cancer	0.00456	0.00456	CbGpPWpGaD
Pergolide—HTR1D—GPCR downstream signaling—GAST—duodenum cancer	0.00454	0.00454	CbGpPWpGaD
Pergolide—ADRA2A—GPCR ligand binding—SCT—duodenum cancer	0.00446	0.00446	CbGpPWpGaD
Pergolide—HTR1B—GPCR downstream signaling—GAST—duodenum cancer	0.00444	0.00444	CbGpPWpGaD
Pergolide—DRD4—GPCR downstream signaling—GAST—duodenum cancer	0.00437	0.00437	CbGpPWpGaD
Pergolide—HTR1D—GPCR downstream signaling—SCT—duodenum cancer	0.0043	0.0043	CbGpPWpGaD
Pergolide—ADRA2B—GPCR ligand binding—SST—duodenum cancer	0.00425	0.00425	CbGpPWpGaD
Pergolide—ADRA2A—Class A/1 (Rhodopsin-like receptors)—SST—duodenum cancer	0.00424	0.00424	CbGpPWpGaD
Pergolide—HTR1B—GPCR downstream signaling—SCT—duodenum cancer	0.00421	0.00421	CbGpPWpGaD
Pergolide—HTR2B—GPCR downstream signaling—GAST—duodenum cancer	0.00417	0.00417	CbGpPWpGaD
Pergolide—DRD4—GPCR downstream signaling—SCT—duodenum cancer	0.00415	0.00415	CbGpPWpGaD
Pergolide—HTR1D—Signaling by GPCR—GAST—duodenum cancer	0.00412	0.00412	CbGpPWpGaD
Pergolide—HTR1A—GPCR ligand binding—SST—duodenum cancer	0.00411	0.00411	CbGpPWpGaD
Pergolide—HTR2C—GPCR ligand binding—SST—duodenum cancer	0.00408	0.00408	CbGpPWpGaD
Pergolide—DRD5—GPCR downstream signaling—SST—duodenum cancer	0.00406	0.00406	CbGpPWpGaD
Pergolide—HTR1B—Signaling by GPCR—GAST—duodenum cancer	0.00404	0.00404	CbGpPWpGaD
Pergolide—ADRA2C—GPCR ligand binding—SST—duodenum cancer	0.00397	0.00397	CbGpPWpGaD
Pergolide—DRD4—Signaling by GPCR—GAST—duodenum cancer	0.00397	0.00397	CbGpPWpGaD
Pergolide—HTR2B—GPCR downstream signaling—SCT—duodenum cancer	0.00396	0.00396	CbGpPWpGaD
Pergolide—DRD1—GPCR downstream signaling—GAST—duodenum cancer	0.00394	0.00394	CbGpPWpGaD
Pergolide—ADRA1B—GPCR ligand binding—SST—duodenum cancer	0.00391	0.00391	CbGpPWpGaD
Pergolide—HTR1D—Signaling by GPCR—SCT—duodenum cancer	0.00391	0.00391	CbGpPWpGaD
Pergolide—ADRA1D—GPCR downstream signaling—GAST—duodenum cancer	0.00388	0.00388	CbGpPWpGaD
Pergolide—DRD3—GPCR downstream signaling—GAST—duodenum cancer	0.00388	0.00388	CbGpPWpGaD
Pergolide—HTR1B—Signaling by GPCR—SCT—duodenum cancer	0.00383	0.00383	CbGpPWpGaD
Pergolide—HTR2B—Signaling by GPCR—GAST—duodenum cancer	0.00379	0.00379	CbGpPWpGaD
Pergolide—DRD4—Signaling by GPCR—SCT—duodenum cancer	0.00376	0.00376	CbGpPWpGaD
Pergolide—DRD1—GPCR downstream signaling—SCT—duodenum cancer	0.00373	0.00373	CbGpPWpGaD
Pergolide—DRD5—Signaling by GPCR—SST—duodenum cancer	0.00369	0.00369	CbGpPWpGaD
Pergolide—ADRA1D—GPCR downstream signaling—SCT—duodenum cancer	0.00368	0.00368	CbGpPWpGaD
Pergolide—DRD3—GPCR downstream signaling—SCT—duodenum cancer	0.00368	0.00368	CbGpPWpGaD
Pergolide—DRD2—GPCR ligand binding—SST—duodenum cancer	0.0036	0.0036	CbGpPWpGaD
Pergolide—HTR2B—Signaling by GPCR—SCT—duodenum cancer	0.00359	0.00359	CbGpPWpGaD
Pergolide—DRD1—Signaling by GPCR—GAST—duodenum cancer	0.00357	0.00357	CbGpPWpGaD
Pergolide—HTR2A—GPCR ligand binding—SST—duodenum cancer	0.00355	0.00355	CbGpPWpGaD
Pergolide—ADRA1D—Signaling by GPCR—GAST—duodenum cancer	0.00353	0.00353	CbGpPWpGaD
Pergolide—DRD3—Signaling by GPCR—GAST—duodenum cancer	0.00353	0.00353	CbGpPWpGaD
Pergolide—ADRA2B—GPCR downstream signaling—GAST—duodenum cancer	0.00351	0.00351	CbGpPWpGaD
Pergolide—ADRA1A—GPCR ligand binding—SST—duodenum cancer	0.00347	0.00347	CbGpPWpGaD
Pergolide—DRD1—Signaling by GPCR—SCT—duodenum cancer	0.00339	0.00339	CbGpPWpGaD
Pergolide—HTR1A—GPCR downstream signaling—GAST—duodenum cancer	0.00338	0.00338	CbGpPWpGaD
Pergolide—HTR2C—GPCR downstream signaling—GAST—duodenum cancer	0.00337	0.00337	CbGpPWpGaD
Pergolide—ADRA1D—Signaling by GPCR—SCT—duodenum cancer	0.00334	0.00334	CbGpPWpGaD
Pergolide—DRD3—Signaling by GPCR—SCT—duodenum cancer	0.00334	0.00334	CbGpPWpGaD
Pergolide—ADRA2B—GPCR downstream signaling—SCT—duodenum cancer	0.00332	0.00332	CbGpPWpGaD
Pergolide—ADRA2C—GPCR downstream signaling—GAST—duodenum cancer	0.00328	0.00328	CbGpPWpGaD
Pergolide—ADRA2A—GPCR ligand binding—SST—duodenum cancer	0.00323	0.00323	CbGpPWpGaD
Pergolide—ADRA1B—GPCR downstream signaling—GAST—duodenum cancer	0.00322	0.00322	CbGpPWpGaD
Pergolide—HTR1A—GPCR downstream signaling—SCT—duodenum cancer	0.00321	0.00321	CbGpPWpGaD
Pergolide—HTR2C—GPCR downstream signaling—SCT—duodenum cancer	0.00319	0.00319	CbGpPWpGaD
Pergolide—ADRA2B—Signaling by GPCR—GAST—duodenum cancer	0.00318	0.00318	CbGpPWpGaD
Pergolide—DRD5—Signaling Pathways—GAST—duodenum cancer	0.00318	0.00318	CbGpPWpGaD
Pergolide—HTR1D—GPCR downstream signaling—SST—duodenum cancer	0.00311	0.00311	CbGpPWpGaD
Pergolide—ADRA2C—GPCR downstream signaling—SCT—duodenum cancer	0.0031	0.0031	CbGpPWpGaD
Pergolide—HTR1A—Signaling by GPCR—GAST—duodenum cancer	0.00307	0.00307	CbGpPWpGaD
Pergolide—HTR2C—Signaling by GPCR—GAST—duodenum cancer	0.00306	0.00306	CbGpPWpGaD
Pergolide—ADRA1B—GPCR downstream signaling—SCT—duodenum cancer	0.00306	0.00306	CbGpPWpGaD
Pergolide—HTR1B—GPCR downstream signaling—SST—duodenum cancer	0.00305	0.00305	CbGpPWpGaD
Pergolide—ADRA2B—Signaling by GPCR—SCT—duodenum cancer	0.00302	0.00302	CbGpPWpGaD
Pergolide—DRD5—Signaling Pathways—SCT—duodenum cancer	0.00301	0.00301	CbGpPWpGaD
Pergolide—DRD4—GPCR downstream signaling—SST—duodenum cancer	0.003	0.003	CbGpPWpGaD
Pergolide—ADRA2C—Signaling by GPCR—GAST—duodenum cancer	0.00297	0.00297	CbGpPWpGaD
Pergolide—DRD2—GPCR downstream signaling—GAST—duodenum cancer	0.00297	0.00297	CbGpPWpGaD
Pergolide—ADRA1B—Signaling by GPCR—GAST—duodenum cancer	0.00293	0.00293	CbGpPWpGaD
Pergolide—HTR2A—GPCR downstream signaling—GAST—duodenum cancer	0.00292	0.00292	CbGpPWpGaD
Pergolide—HTR1A—Signaling by GPCR—SCT—duodenum cancer	0.00291	0.00291	CbGpPWpGaD
Pergolide—HTR2C—Signaling by GPCR—SCT—duodenum cancer	0.0029	0.0029	CbGpPWpGaD
Pergolide—ADRA1A—GPCR downstream signaling—GAST—duodenum cancer	0.00286	0.00286	CbGpPWpGaD
Pergolide—HTR2B—GPCR downstream signaling—SST—duodenum cancer	0.00286	0.00286	CbGpPWpGaD
Pergolide—HTR1D—Signaling by GPCR—SST—duodenum cancer	0.00282	0.00282	CbGpPWpGaD
Pergolide—ADRA2C—Signaling by GPCR—SCT—duodenum cancer	0.00282	0.00282	CbGpPWpGaD
Pergolide—DRD2—GPCR downstream signaling—SCT—duodenum cancer	0.00282	0.00282	CbGpPWpGaD
Pergolide—ADRA1B—Signaling by GPCR—SCT—duodenum cancer	0.00278	0.00278	CbGpPWpGaD
Pergolide—HTR2A—GPCR downstream signaling—SCT—duodenum cancer	0.00277	0.00277	CbGpPWpGaD
Pergolide—HTR1B—Signaling by GPCR—SST—duodenum cancer	0.00277	0.00277	CbGpPWpGaD
Pergolide—DRD4—Signaling by GPCR—SST—duodenum cancer	0.00272	0.00272	CbGpPWpGaD
Pergolide—ADRA1A—GPCR downstream signaling—SCT—duodenum cancer	0.00271	0.00271	CbGpPWpGaD
Pergolide—DRD2—Signaling by GPCR—GAST—duodenum cancer	0.0027	0.0027	CbGpPWpGaD
Pergolide—DRD1—GPCR downstream signaling—SST—duodenum cancer	0.0027	0.0027	CbGpPWpGaD
Pergolide—ADRA1D—GPCR downstream signaling—SST—duodenum cancer	0.00266	0.00266	CbGpPWpGaD
Pergolide—DRD3—GPCR downstream signaling—SST—duodenum cancer	0.00266	0.00266	CbGpPWpGaD
Pergolide—ADRA2A—GPCR downstream signaling—GAST—duodenum cancer	0.00266	0.00266	CbGpPWpGaD
Pergolide—HTR2A—Signaling by GPCR—GAST—duodenum cancer	0.00266	0.00266	CbGpPWpGaD
Pergolide—DRD5—Signaling Pathways—MEN1—duodenum cancer	0.00263	0.00263	CbGpPWpGaD
Pergolide—ADRA1A—Signaling by GPCR—GAST—duodenum cancer	0.0026	0.0026	CbGpPWpGaD
Pergolide—HTR2B—Signaling by GPCR—SST—duodenum cancer	0.0026	0.0026	CbGpPWpGaD
Pergolide—DRD2—Signaling by GPCR—SCT—duodenum cancer	0.00256	0.00256	CbGpPWpGaD
Pergolide—ADRA2A—GPCR downstream signaling—SCT—duodenum cancer	0.00252	0.00252	CbGpPWpGaD
Pergolide—HTR2A—Signaling by GPCR—SCT—duodenum cancer	0.00252	0.00252	CbGpPWpGaD
Pergolide—ADRA1A—Signaling by GPCR—SCT—duodenum cancer	0.00246	0.00246	CbGpPWpGaD
Pergolide—DRD1—Signaling by GPCR—SST—duodenum cancer	0.00245	0.00245	CbGpPWpGaD
Pergolide—HTR1D—Signaling Pathways—GAST—duodenum cancer	0.00243	0.00243	CbGpPWpGaD
Pergolide—DRD3—Signaling by GPCR—SST—duodenum cancer	0.00242	0.00242	CbGpPWpGaD
Pergolide—ADRA1D—Signaling by GPCR—SST—duodenum cancer	0.00242	0.00242	CbGpPWpGaD
Pergolide—ADRA2A—Signaling by GPCR—GAST—duodenum cancer	0.00242	0.00242	CbGpPWpGaD
Pergolide—ADRA2B—GPCR downstream signaling—SST—duodenum cancer	0.0024	0.0024	CbGpPWpGaD
Pergolide—HTR1B—Signaling Pathways—GAST—duodenum cancer	0.00238	0.00238	CbGpPWpGaD
Pergolide—DRD4—Signaling Pathways—GAST—duodenum cancer	0.00235	0.00235	CbGpPWpGaD
Pergolide—HTR1A—GPCR downstream signaling—SST—duodenum cancer	0.00232	0.00232	CbGpPWpGaD
Pergolide—HTR2C—GPCR downstream signaling—SST—duodenum cancer	0.00231	0.00231	CbGpPWpGaD
Pergolide—HTR1D—Signaling Pathways—SCT—duodenum cancer	0.00231	0.00231	CbGpPWpGaD
Pergolide—ADRA2A—Signaling by GPCR—SCT—duodenum cancer	0.00229	0.00229	CbGpPWpGaD
Pergolide—HTR1B—Signaling Pathways—SCT—duodenum cancer	0.00226	0.00226	CbGpPWpGaD
Pergolide—ADRA2C—GPCR downstream signaling—SST—duodenum cancer	0.00224	0.00224	CbGpPWpGaD
Pergolide—HTR2B—Signaling Pathways—GAST—duodenum cancer	0.00224	0.00224	CbGpPWpGaD
Pergolide—DRD4—Signaling Pathways—SCT—duodenum cancer	0.00222	0.00222	CbGpPWpGaD
Pergolide—ADRA1B—GPCR downstream signaling—SST—duodenum cancer	0.00221	0.00221	CbGpPWpGaD
Pergolide—ADRA2B—Signaling by GPCR—SST—duodenum cancer	0.00218	0.00218	CbGpPWpGaD
Pergolide—DRD5—Signaling Pathways—SST—duodenum cancer	0.00218	0.00218	CbGpPWpGaD
Pergolide—HTR2B—Signaling Pathways—SCT—duodenum cancer	0.00212	0.00212	CbGpPWpGaD
Pergolide—DRD1—Signaling Pathways—GAST—duodenum cancer	0.00211	0.00211	CbGpPWpGaD
Pergolide—HTR1A—Signaling by GPCR—SST—duodenum cancer	0.00211	0.00211	CbGpPWpGaD
Pergolide—HTR2C—Signaling by GPCR—SST—duodenum cancer	0.0021	0.0021	CbGpPWpGaD
Pergolide—ADRA1D—Signaling Pathways—GAST—duodenum cancer	0.00208	0.00208	CbGpPWpGaD
Pergolide—DRD3—Signaling Pathways—GAST—duodenum cancer	0.00208	0.00208	CbGpPWpGaD
Pergolide—ADRA2C—Signaling by GPCR—SST—duodenum cancer	0.00204	0.00204	CbGpPWpGaD
Pergolide—DRD2—GPCR downstream signaling—SST—duodenum cancer	0.00204	0.00204	CbGpPWpGaD
Pergolide—HTR1D—Signaling Pathways—MEN1—duodenum cancer	0.00202	0.00202	CbGpPWpGaD
Pergolide—ADRA1B—Signaling by GPCR—SST—duodenum cancer	0.00201	0.00201	CbGpPWpGaD
Pergolide—HTR2A—GPCR downstream signaling—SST—duodenum cancer	0.002	0.002	CbGpPWpGaD
Pergolide—DRD1—Signaling Pathways—SCT—duodenum cancer	0.002	0.002	CbGpPWpGaD
Pergolide—DRD3—Signaling Pathways—SCT—duodenum cancer	0.00198	0.00198	CbGpPWpGaD
Pergolide—ADRA1D—Signaling Pathways—SCT—duodenum cancer	0.00198	0.00198	CbGpPWpGaD
Pergolide—HTR1B—Signaling Pathways—MEN1—duodenum cancer	0.00198	0.00198	CbGpPWpGaD
Pergolide—ADRA1A—GPCR downstream signaling—SST—duodenum cancer	0.00196	0.00196	CbGpPWpGaD
Pergolide—DRD4—Signaling Pathways—MEN1—duodenum cancer	0.00194	0.00194	CbGpPWpGaD
Pergolide—ADRA2B—Signaling Pathways—GAST—duodenum cancer	0.00188	0.00188	CbGpPWpGaD
Pergolide—HTR2B—Signaling Pathways—MEN1—duodenum cancer	0.00186	0.00186	CbGpPWpGaD
Pergolide—DRD2—Signaling by GPCR—SST—duodenum cancer	0.00185	0.00185	CbGpPWpGaD
Pergolide—ADRA2A—GPCR downstream signaling—SST—duodenum cancer	0.00182	0.00182	CbGpPWpGaD
Pergolide—HTR2A—Signaling by GPCR—SST—duodenum cancer	0.00182	0.00182	CbGpPWpGaD
Pergolide—HTR1A—Signaling Pathways—GAST—duodenum cancer	0.00182	0.00182	CbGpPWpGaD
Pergolide—HTR2C—Signaling Pathways—GAST—duodenum cancer	0.00181	0.00181	CbGpPWpGaD
Pergolide—ADRA2B—Signaling Pathways—SCT—duodenum cancer	0.00178	0.00178	CbGpPWpGaD
Pergolide—ADRA1A—Signaling by GPCR—SST—duodenum cancer	0.00178	0.00178	CbGpPWpGaD
Pergolide—ADRA2C—Signaling Pathways—GAST—duodenum cancer	0.00176	0.00176	CbGpPWpGaD
Pergolide—DRD1—Signaling Pathways—MEN1—duodenum cancer	0.00175	0.00175	CbGpPWpGaD
Pergolide—ADRA1B—Signaling Pathways—GAST—duodenum cancer	0.00173	0.00173	CbGpPWpGaD
Pergolide—ADRA1D—Signaling Pathways—MEN1—duodenum cancer	0.00173	0.00173	CbGpPWpGaD
Pergolide—DRD3—Signaling Pathways—MEN1—duodenum cancer	0.00173	0.00173	CbGpPWpGaD
Pergolide—HTR1A—Signaling Pathways—SCT—duodenum cancer	0.00172	0.00172	CbGpPWpGaD
Pergolide—HTR2C—Signaling Pathways—SCT—duodenum cancer	0.00171	0.00171	CbGpPWpGaD
Pergolide—HTR1D—Signaling Pathways—SST—duodenum cancer	0.00167	0.00167	CbGpPWpGaD
Pergolide—ADRA2C—Signaling Pathways—SCT—duodenum cancer	0.00167	0.00167	CbGpPWpGaD
Pergolide—ADRA2A—Signaling by GPCR—SST—duodenum cancer	0.00166	0.00166	CbGpPWpGaD
Pergolide—ADRA1B—Signaling Pathways—SCT—duodenum cancer	0.00164	0.00164	CbGpPWpGaD
Pergolide—HTR1B—Signaling Pathways—SST—duodenum cancer	0.00163	0.00163	CbGpPWpGaD
Pergolide—DRD4—Signaling Pathways—SST—duodenum cancer	0.00161	0.00161	CbGpPWpGaD
Pergolide—DRD2—Signaling Pathways—GAST—duodenum cancer	0.00159	0.00159	CbGpPWpGaD
Pergolide—HTR2A—Signaling Pathways—GAST—duodenum cancer	0.00157	0.00157	CbGpPWpGaD
Pergolide—ADRA2B—Signaling Pathways—MEN1—duodenum cancer	0.00156	0.00156	CbGpPWpGaD
Pergolide—ADRA1A—Signaling Pathways—GAST—duodenum cancer	0.00154	0.00154	CbGpPWpGaD
Pergolide—HTR2B—Signaling Pathways—SST—duodenum cancer	0.00153	0.00153	CbGpPWpGaD
Pergolide—DRD2—Signaling Pathways—SCT—duodenum cancer	0.00151	0.00151	CbGpPWpGaD
Pergolide—HTR1A—Signaling Pathways—MEN1—duodenum cancer	0.0015	0.0015	CbGpPWpGaD
Pergolide—HTR2C—Signaling Pathways—MEN1—duodenum cancer	0.0015	0.0015	CbGpPWpGaD
Pergolide—HTR2A—Signaling Pathways—SCT—duodenum cancer	0.00149	0.00149	CbGpPWpGaD
Pergolide—ADRA1A—Signaling Pathways—SCT—duodenum cancer	0.00146	0.00146	CbGpPWpGaD
Pergolide—ADRA2C—Signaling Pathways—MEN1—duodenum cancer	0.00146	0.00146	CbGpPWpGaD
Pergolide—DRD1—Signaling Pathways—SST—duodenum cancer	0.00145	0.00145	CbGpPWpGaD
Pergolide—ADRA1B—Signaling Pathways—MEN1—duodenum cancer	0.00143	0.00143	CbGpPWpGaD
Pergolide—DRD3—Signaling Pathways—SST—duodenum cancer	0.00143	0.00143	CbGpPWpGaD
Pergolide—ADRA1D—Signaling Pathways—SST—duodenum cancer	0.00143	0.00143	CbGpPWpGaD
Pergolide—ADRA2A—Signaling Pathways—GAST—duodenum cancer	0.00143	0.00143	CbGpPWpGaD
Pergolide—ADRA2A—Signaling Pathways—SCT—duodenum cancer	0.00135	0.00135	CbGpPWpGaD
Pergolide—DRD2—Signaling Pathways—MEN1—duodenum cancer	0.00132	0.00132	CbGpPWpGaD
Pergolide—HTR2A—Signaling Pathways—MEN1—duodenum cancer	0.0013	0.0013	CbGpPWpGaD
Pergolide—ADRA2B—Signaling Pathways—SST—duodenum cancer	0.00129	0.00129	CbGpPWpGaD
Pergolide—ADRA1A—Signaling Pathways—MEN1—duodenum cancer	0.00127	0.00127	CbGpPWpGaD
Pergolide—HTR1A—Signaling Pathways—SST—duodenum cancer	0.00124	0.00124	CbGpPWpGaD
Pergolide—HTR2C—Signaling Pathways—SST—duodenum cancer	0.00124	0.00124	CbGpPWpGaD
Pergolide—ADRA2C—Signaling Pathways—SST—duodenum cancer	0.0012	0.0012	CbGpPWpGaD
Pergolide—ADRA1B—Signaling Pathways—SST—duodenum cancer	0.00119	0.00119	CbGpPWpGaD
Pergolide—ADRA2A—Signaling Pathways—MEN1—duodenum cancer	0.00118	0.00118	CbGpPWpGaD
Pergolide—DRD2—Signaling Pathways—SST—duodenum cancer	0.00109	0.00109	CbGpPWpGaD
Pergolide—HTR2A—Signaling Pathways—SST—duodenum cancer	0.00108	0.00108	CbGpPWpGaD
Pergolide—ADRA1A—Signaling Pathways—SST—duodenum cancer	0.00105	0.00105	CbGpPWpGaD
Pergolide—ADRA2A—Signaling Pathways—SST—duodenum cancer	0.000978	0.000978	CbGpPWpGaD
